VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESGO 2021 | Gynecological cancers: co-morbidities and best supportive care

Jalid Sehouli • 24 Oct 2021
ESGO 2021
Endometrial Cancer Gynecological Cancer Ovarian Cancer

Jalid Sehouli, MD, Charité University of Medicine Berlin, Berlin, Germany, discusses how co-morbidities affect the management of gynecological cancers, and suggests how to give patients the best supportive care. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

More from Jalid Sehouli

1:04
The importance of encouraging patients to talk about symptoms
Jalid Sehouli • 1 Jun 2018
1:29
Quality of life can impact PFS in ovarian cancer
Jalid Sehouli • 1 Jun 2018
2:54
Determining the quality of life in long-term survivors of ovarian cancer
Jalid Sehouli
1:37
KORE Innovation trial: an enhanced perioperative pathway for patients with ovarian cancer
Jalid Sehouli • 24 Oct 2021

Related Videos

0:50
Combinatorial PARPi therapies in advanced endometrial cancer
Benoit You • 11 Apr 2022
2:01
ENDOLA: olaparib, metronomic cyclophosphamide and metformin in advanced endometrial cancer
Benoit You • 11 Apr 2022
0:49
Research priorities for metastatic endometrial cancer
Benoit You • 11 Apr 2022
1:47
Advances in precision therapy for ovarian cancer
Don Dizon • 26 Feb 2022
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals